EAM
ALXN

Erste Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Erste Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-53,000
Closed -$9.77M – 533
2021
Q2 		$9.77M Sell
53,000
-4,650
-8% -$798K 0.19% 135
2021
Q1 		$8.85M Hold
57,650
– – 0.22% 131
2020
Q4 		$8.96M Sell
57,650
-13,300
-19% -$1.71M 0.25% 118
2020
Q3 		$7.98M Hold
70,950
– – 0.27% 107
2020
Q2 		$7.89M Hold
70,950
– – 0.32% 97
2020
Q1 		$6.19M Sell
70,950
-9,500
-12% -$932K 0.36% 82
2019
Q4 		$8.73M Buy
80,450
+6,200
+8% +$663K 0.39% 67
2019
Q3 		$7.26M Hold
74,250
– – 0.39% 68
2019
Q2 		$9.36M Buy
74,250
+4,100
+6% +$528K 0.5% 49
2019
Q1 		$9.35M Hold
70,150
– – 0.52% 42
2018
Q4 		$6.88M Buy
+70,150
New +$8.29M 0.46% 49

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Erste Asset Management's ALXN Position: Q3 2021 in Review

Erste Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 53,000 shares — an estimated $9.77M sold.

Erste Asset Management first reported a position in ALXN in Q4 2018 and held it in 11 quarters. The position peaked at $9.77M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Erste Asset Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Erste Asset Management sold 53,000 Alexion Pharmaceuticals shares in Q3 2021, an estimated $9.77M.
  • Erste Asset Management first reported a position in Alexion Pharmaceuticals in Q4 2018 and held it in 11 quarters.
  • Erste Asset Management's Alexion Pharmaceuticals position peaked at $9.77M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Erste Asset Management's 13F filing for Q3 2021, filed 25 Nov 2024.